TB chemoprophylaxis Graham Bothamley Clinical Director, NE London TB Network.

Slides:

Advertisements

Similar presentations

Contact Evaluation Your name Institution/organization Meeting Date International Standards 18, 19.

Advertisements

Implementing NICE guidance

A typical day in the TB clinic You see the following patients in the TB clinic. All have normal CXRs: 1. A 35 year old man from Hartford with a 16 mm positive.

Tuberculosis in Children: Prevention Module 10C - March 2010.

Continuity Clinic Tuberculosis. Continuity Clinic Objectives Know current epidemiologic trends in TB Know indications for testing for TB exposure and.

Latent TB When infected with M Tuberculosis, but do not have active tuberculosis disease. Patients are not infectious. TB infections in Australia are predominantly.

TB Presentation for Healthcare Students

OSHA Blood Borne Pathogen and Tuberculosis Training PART II Tuberculosis Author: Maxine Edwards, RN, ICP ECU Infection Control Presented by: Patti Goetz,

Screening of Latent Tuberculosis before treatment with TNF  blockers Ori Elkayam M.D Tel Aviv Medical Center.

Prevention Bacille Calmette Guerin (BCG) Vaccine Live attenuated strain of Mycobacterium bovis; 1921 Efficacy Clinical trials UK: protective effect of.

Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.

MD: Universidad Autónoma de Guadalajara, México, 1975 MPH: Graduate School of Public Health, San Diego State University, 1990 Pulmonologist, Hospital General.

BCG complications.

“You want me to take how many months of medication?”:

Latent Tuberculosis among Displaced Populations Rapid Diagnosis and Control Nikolaou Aristidis MD, MSc.

Newham CCG Latent Tuberculosis Screening and Treatment Programme 28 th March 2014 Dr Margaret Chirgwin – Programme Director Primary Care Strategy.

Jean-Pierre Zellweger Swiss Lung Association Berne, Switzerland

October 3, Serial Testing of Health Care Workers for Tuberculosis Using Interferon-γ Assay Madhukar Pai, et. al. American Journal of Respiratory.

Unit 5: IPT Isoniazid TB Preventive Therapy

TB or not TB ? Mahmoud Abu-Shakra Rheumatic disease Unit

Diagnosing and Treating Latent TB Infection (LTBI)

Current international guidelines recommend 6–9 months of isoniazid (INH) preventive chemotherapy to prevent the development of active tuberculosis in.

Allen Kraut, MD, FRCPC Medical Director, Occupational Health WRHA

 Pulmonary Tuberculosis BY: MOHAMED HUSSEIN. Cause  Caused by Mycobacterium tuberculosis (M. tuberculosis)  Gram (+) rod (bacilli). Acid-fast  Pulmonary.

Tuberculosis. What Is It? Bacterial infectionBacterial infection Caused by Mycobacterium tuberculosis (also called tubercle bacillus)Caused by Mycobacterium.

TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.

New Entrant TB Screening Dr. John P. Watson Consultant Respiratory Physician.

IGRAs in Practice: The San Francisco Health Department Experience Jennifer Grinsdale, MPH Program Manager/Epidemiologist Acting Director Tuberculosis Control.

“Don’t tell me TB is under control!” Understanding TB

THEME: PULMONARY TUBERCULOSIS ESSAY Kazakh National medical university named after S.D. Asfendiyarov Department of foreign languages Made by: Kalymzhan.

Microbiologists from Mexico at South Texas Hospital Lab “Microbiólogos de México en el laboratorio de South Texas Hospital”

Adult Medical-Surgical Nursing Respiratory Module: Tuberculosis.

Tuberculosis The evolution of a bacterium. 2 World Health Organization (WH.O. declared TB a global health emergency in cases per 100,

Screening for TB.

بسم الله الرحمن الرحيم. A 25 year old Saudi male applied to work as paramedic. He has no symptoms or history of contact with sick patients. His physical.

IGRAs: Should they replace the TST in the identification of latent tuberculosis? Objectives Describe how interferon-gamma release assays (IGRAs) work.

Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.

Mantoux tuberculin skin test

A Self Study Powerpoint

Contact Investigation Dr. Essam Elmoghazy. Contact Investigations – A Crucial Prevention Strategy On average, 10 contacts are identified for each person.

Tuberculosis in Children and Young Adults

BCG Vaccination Dr Lika Nehaul. Acknowledgements Nature (Scientific) Publishing Group Health Protection Agency World Health Organisation.

“You want me to take how many months of medication?”: Advising your patient on risks vs. benefits of LTBI treatment David Horne, MD, MPH Division of Pulmonary.

The Epidemiology of Tuberculosis Lex Gibson, Director Virginia TB Program.

Diagnosis of pulmonary tuberculosis

The Strategic Health Authority for London London and TB 4 October 2007 Lynn Altass NHSL Public Health – TB North Central London TB Network Manager.

TB PREVENTION by Assoc. Prof. Dr. Nik Sherina Haidi Hanafi 1.

Depart. of Pulmonology 백승숙. More than 80% of cases of tuberculosis in the United States –The result of reactivated latent infection –Nearly all these.

Latent Tuberculosis Infection Georges KHAYAT Associate Professor, Faculté de Médecine, Université Saint Joseph.

EPIDEMIOLOGY OF PULMONARY TUBERCULOSIS. LEARNIN G OBJECTIVES State the diagnostic criteria of pulmonary tuberculosis Describe trend & state reasons for.

Shingai Machingaidze, Suzanne Verver, Humphrey Mulenga, Deborah-Ann Abrahams, Mark Hatherill, Willem Hanekom, Gregory D. Hussey, and Hassan Mahomed Am.

TB: The Elispot In The Room Dr Jessica Potter TB Research Registrar Barts Health NHS Trust.

Tuberculosis in children

TB Disease and Infection

Tuberculosis (TB) PHCL 442 Lab Discussion 4 Raniah Al-Jaizani M.Sc.

Institute for Health Service Research for Healthcare Workers (CVcare)

TB Awareness Practice Nurses

Indeterminate and inconclusive results are common when using Interferon Gamma Release Assay as screening for TB in patients with IBD Nasr I, Goel RM, Ward.

This is an archived document.

Figure 1. Paradigm for evaluation of those with latent tuberculosis infection (LTBI) based on risk of infection, risk of progression to tuberculosis, and.

This is an archived document.

Epidemiology of pulmonary tuberculosis

CDC Guidelines for Use of QuantiFERON®-TB Gold Test

بسم الله الرحمن الرحيم.

Tolerability of Isoniazid Preventive therapy Among HIV infected Cohort in Nigeria Folajinmi Oluwasina Strategic Information Unit AIDS Healthcare Foundation,

Tb: Screening & Diagnosis (1)

BCG Vaccination Dr Lika Nehaul CCDC / NPHS TB Programme Lead

Tuberculosis is an infection that is transmitted though airborne particles. It is an uncommon infection in Canada, but is still seen in indigenous populations.

5th edition NTP MANUAL OF PROCEDURES Case Finding

Presentation transcript:

TB chemoprophylaxis Graham Bothamley Clinical Director, NE London TB Network

Questions 1.Do we know who will develop TB? 2.Who should take treatment? 3.How many will receive unnecessary treatment? 4.How many actually take treatment? 5.Is it cost-effective? 6.Is isoniazid the right treatment?

Latent TB infection or long-lasting TB immunity? Cochrane review: 1.68% over 5 years HIV+ PPD+ cohort: 4% over 22 months (7.9 cases per 100 person years) Human macrophages cannot kill Mtb 1-3 tubercle bacilli required for disease Selwyn et al NEJM 320: 545

Children: tuberculin responses, risk of TB over first 9 years and timing of exposure Horsburgh. NEJM 2004; 350:2060 US data:

Adults: tuberculin responses, risk of TB over first 9 years and timing of exposure Horsburgh. NEJM 2004; 350:2060 US data:

Progression to TB Immigrant contacts of S+ve cases >16 yrs in Holland CriterionTB cases/ positives % (95% CI) Sensitivity (%) PPD  10 mm 9/ ( )100 PPD  15 mm 7/ ( )88 QFT-GIT5/ ( )63 T-SPOT.TB6/ ( )75 All IGRA patients had PPD>10 mm; 1/8 patients missed if 15 mm Kaplan Meier for progression, pos vs. neg: even PPD >15 mm P= contacts from 380 index cases Kik et al. Eur Respir J 2010; (in press)

Predictive values of IGRA Subjects (n) Tests (n) False results Mean % Range % NPV PPV / PPV-HIV / TBNET review: Diel et al (ECDC)

PPD+: NNT to prevent 1 case TB ConditionNNTConditionNNT Transplant5Diabetes53.5 HIV+13.5Silicosis61 Gastrectomy23.5Unexplained WL66.5 Child contact24.5CRF on dialysis67 PPD conversion24.5Leukaemia91 IVDU30.5Immigrants93 Steroids98.5 No risk123.5 Rose. Arch Intern Med 2000; 160:1513

Treatment and harm Treat 72 to prevent one case of TB Treat 333 to cause isoniazid induced hepatitis (varies with age)

Hepatotoxicity of isoniazid Comstock & Edwards. Am Rev Respir Dis 1795; 111: 573

Adherence Horsburgh et al. Chest 2010; 137: clinics 123/720 declined (17.1%: %) 1045/1994 (52.4%) failed to complete IJTLD 2008; 12: 1235 & seen 8 had TB (0.2%) PPD+ = refused and only 40% eligible (>35 yrs) 320 (8.9% total; 67% who started) completed

Isoniazid Active against rapidly dividing population Course longer than TB treatment Most hepatotoxic of TB drugs Cheap

Chemoprophylaxis? 3 year old Mother has smear-positive pulmonary tuberculosis BCG vaccinated PPD 5 mm response

Chemoprophylaxis? 16 year old Somali Mother had LN TB BCG vaccinated PPD 12 mm response

Chemoprophylaxis? 34 year old Russian Screened as a new entrant to EU Chest x-ray normal PPD 35 mm response

Chemoprophylaxis? 45 year old health care worker Occupational health screening To work with HIV+ Born in UK Visited relatives in India for 3m last year Chest x-ray normal PPD 16 mm response

Chemoprophylaxis? 37 year old from Guinea-Bissau HIV+ BCG vaccinated PPD 15 mm response

Chemoprophylaxis? 45 year old from Turkey Screened as new entrant BCG vaccinated Chest x-ray: one calcified granuloma PPD 12 mm response Quantiferon: 0.52 IU/ml (>0.35 IU/ml)